SCHEMBL7218537

SCHEMBL7218537

CCNC(=O)c1csc(Cl)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 4/20 0.43
KDM4E B2RXH2 2/20 0.43
GAA P10253 3/20 0.42
HIF1A Q16665 1/20 0.41
RAB9A P51151 2/20 0.41
PANK3 Q9H999 1/20 0.40
HPGD P15428 3/20 0.40
CYP1A2 P05177 3/20 0.40
CYP3A4 P08684 3/20 0.40
CYP2C9 P11712 3/20 0.40
CYP2C19 P33261 3/20 0.40
CYP2D6 P10635 1/20 0.40
MAPT P10636 1/20 0.40
HTT P42858 1/20 0.40
NPC1 O15118 1/20 0.39
CNR1 P21554 1/20 0.39
BRD4 O60885 1/20 0.39
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9328736 0.84 KDM4E (0.48) TLR7KDM4EGAAHIF1APANK3
SCHEMBL2642829 0.81 HIF1A (0.60) TLR7KDM4EHIF1ARAB9AHPGD
SCHEMBL163960 0.81 HIF1A (0.42) GAAHIF1ARAB9AHPGDCYP1A2
SCHEMBL11500010 0.80 NPSR1 (0.49) TLR7KDM4EGAARAB9ACYP1A2
SCHEMBL299830 0.80 RAB9A (0.59) TLR7KDM4EGAARAB9AHPGD
SCHEMBL10708147 0.80 HIF1A (0.49) TLR7KDM4EHIF1ARAB9APANK3
SCHEMBL3505795 0.80 MAOB (0.53) TLR7KDM4EHIF1APANK3CYP1A2
SCHEMBL2642628 0.79 ALDH1A1 (0.55) KDM4EGAAHIF1ARAB9AHPGD
SCHEMBL2642827 0.79 HIF1A (0.41) TLR7GAAHIF1ARAB9APANK3
SCHEMBL2643525 0.79 HIF1A (0.41) KDM4EGAAHIF1AHPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023229380-A1 HETEROCYCLIC COMPOUND AS DIACYLGLYCEROL KINASE INHIBITOR AND USE THEREOF 주식회사 엘지화학 2023-11-30 WO disclosed
US-9682995-B2 Amino-substituted isothiazoles BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-06-20 US disclosed
US-9682995-B2 Amino-substituted isothiazoles BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-06-20 US disclosed
EP-2951174-B1 AMINO-SUBSTITUTED ISOTHIAZOLES Bayer Pharma AG (DE) 2017-04-26 EP disclosed
EP-2951174-B1 AMINO-SUBSTITUTED ISOTHIAZOLES Bayer Pharma AG (DE) 2017-04-26 EP disclosed
US-20150368260-A1 AMINO-SUBSTITUTED ISOTHIAZOLES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2015-12-24 US disclosed
US-20150368260-A1 AMINO-SUBSTITUTED ISOTHIAZOLES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2015-12-24 US disclosed
EP-2951174-A1 AMINO-SUBSTITUTED ISOTHIAZOLES Bayer Pharma Aktiengesellschaft (DE) 2015-12-09 EP disclosed
WO-2014118186-A1 AMINO-SUBSTITUTED ISOTHIAZOLES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2014-08-07 WO disclosed
WO-2014118186-A1 AMINO-SUBSTITUTED ISOTHIAZOLES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2014-08-07 WO disclosed
US-RE36562-E CARBOXAMIDE-SUBSTITUTED THIOPHENES MONSANTO COMPANY (US) 2000-02-08 US disclosed
US-5998466-A PREPLANTING MONSANTO COMPANY (US) 1999-12-07 US disclosed
US-5849723-A Fungicides for the control of take-all disease of plants MONSANTO COMPANY (US) 1998-12-15 US disclosed
US-5834447-A THIOPHENE DERIVATIVES MONSANTO COMPANY (US) 1998-11-10 US disclosed
US-5811411-A Fungicides for the control of take-all disease of plants MONSANTO COMPANY (US) 1998-09-22 US disclosed
US-5705513-A HETEROCYCLIC FUNGICIDES WITH PYRIDINE OR FURAN RINGS MONSANTO COMPANY (US) 1998-01-06 US disclosed
US-5693667-A Fungicides for the control of take-all disease of plants MONSANTO COMPANY (US) 1997-12-02 US disclosed
US-5498630-A SUBSTITUTED BENZOTHIOPHENECARBOXAMIDES MONSANTO COMPANY (US) 1996-03-12 US disclosed
WO-1993007751-A1 FUNGICIDES FOR THE CONTROL OF TAKE-ALL DISEASE OF PLANTS MONSANTO COMPANY (US) 1993-04-29 WO disclosed
EP-0538231-A1 Fungicides for the control of take-all disease of plants MONSANTO COMPANY (US) 1993-04-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150368260-A1 AMINO-SUBSTITUTED ISOTHIAZOLES BUB1B, BUB1, CCNB1 TLR7 4348/4885KDM4E 1787/4885GAA 3017/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.